Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05008185 · ClinicalTrials.gov registry record
Regenerative Peripheral Nerve Interfaces to Treat Painful Digit and Hand Neuromas After Amputation
A clinical trial of Neuroma, sponsored by Medstar Health Research Institute.
- Recruiting
- Registry status
- 80
- Enrollment target
- 2
- Study locations
NCT05008185: Recruiting study of Neuroma, sponsored by Medstar Health Research Institute.
NCT05008185 is a study of Neuroma that is actively recruiting participants, run by Medstar Health Research Institute. The registered enrollment target is 80 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05008185, a study of Neuroma, is actively recruiting participants, sponsored by Medstar Health Research Institute.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is being done to demonstrate the effectiveness of Regenerative Peripheral Nerve Interfaces (RPNI) surgery in treating symptomatic neuromas of the hand and digits following amputation compared to standard of care using a Prospective, Observational Trial
Primary Outcome
PROMIS Pain Interference (PROMIS-PI) scale measures the extent to which pain hinders an individual's engagement with physical, mental, cognitive, emotional, recreational, and social activities over the past 7 days answering each questions with a response of not at all, a little bit, somewhat, quite a bit, and very much with not at all being the best and very much the worst.
Conditions Studied
Interventions
- PROCEDURE Regenerative Peripheral Nerve Interface (RPNI) surgery
- PROCEDURE Traction Neurectomy
Study Locations (2)
Maryland
- The Curtis National Hand Center at Medstar Union Memorial Hospital - Baltimore
Michigan
- University of Michigan Plastic Surgery - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-10-05 |
| Est. Completion | 2025-08 |
What NCT05008185 shows while recruiting
NCT05008185 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 1 condition, with Neuroma appearing as the primary indexed condition, and to 2 interventions - of which Regenerative Peripheral Nerve Interface (RPNI) surgery is the first listed.
NCT05008185 reports a single indexed study location in Maryland, Michigan.
Frequently Asked Questions
What is clinical trial NCT05008185 about?
NCT05008185 is a clinical study titled "Regenerative Peripheral Nerve Interfaces to Treat Painful Digit and Hand Neuromas After Amputation". This study is being done to demonstrate the effectiveness of Regenerative Peripheral Nerve Interfaces (RPNI) surgery in treating symptomatic neuromas of the hand and digits following amputation compared to standard of care using a Prospective, Observational Trial
What is the current status of trial NCT05008185?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2021-10-05. Estimated completion is 2025-08.
What conditions does trial NCT05008185 study?
This clinical trial studies the following conditions: Neuroma.
What interventions are being tested in trial NCT05008185?
The interventions under investigation include: Regenerative Peripheral Nerve Interface (RPNI) surgery (PROCEDURE), Traction Neurectomy (PROCEDURE).
Who is sponsoring clinical trial NCT05008185?
This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05008185 being conducted?
This trial has 2 study locations across Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neuroma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI